|
MCS (Medical Compression Systems)
MCS develops, manufactures and markets palm-size, battery-operated pneumatic compression therapy systems targeted at the DVT prevention field and is the first company to offer the market a new class of Continuous Enhanced Circulation Therapy (C.E.C.T) that can replace medication therapy as the current standard of care. With the only clinically proven VTE (blood clot) prevention device to work independently of pharmaceutical agents - and with a price structure on par with drug cost - the company has already penetrated dozens of leading hospitals in the U.S. The company's products are protected by numerous patents, have FDA clearance and are CE approved. MCS Inc., the company's subsidiary, is located in the U.S.
http://www.mcsmed.com
|
|
NLT SPINE (NonLinear Technologies)
NLT Spine develops minimally invasive surgical (MIS) products for treating degenerative spinal conditions. Based on a patented "nonlinear" principle that allows large implants and instruments to be inserted through a small incision in the body, NLT Spine increases patient safety and surgeon control while reducing postoperative complications. NLT Spine has nine patents issued and pending.
http://www.nonlinear-tech.com
|
|
CartiHeal
CartiHeal is the developer of proprietary, biocompatible and biodegradable off-the-shelf implants, for cartilage and bone regeneration. CartiHeal's acellular Agili-C bi-phasic implant is arthroscopically press-fit within a cartilage or osteochondral defect in a single-stage procedure. The implant supports vessels formation within its interconnected porous structure, followed by rapid invasion and adhesion of bone marrow mesenchymal stem cells (MSCs), which then proliferate and differentiate to regenerate the bone and the cartilage. Due to its mechanical strength, the implant has significant load-bearing capability, allowing patients faster rehabilitation and return to normal function, including sports. The Company is ISO 13485 and ISO 9001 certified, and the implants are CE marked.
|
|
PeerMedical
PeerMedical is a privately held company dedicated to the development of innovative medical devices in the endoscopy arena through its proprietary & patented technologies. Our vision is to improve physician outcome through the implementation of new technology that optimizes technique, enhances diagnostics and reduces procedure time. Our technology will offer more benefits to patients within the worldwide GI community.
http://peer-medical.com
|
|
EndoSpan
EndoSpan Ltd. Is a VC-backed clinical-stage medical device start-up, developing a novel endovascular system, intended to provide the next generation in Endo-Vascular Aortic Aneurysm repair (EVAR). EndoSpan’s system aims to achieve a much smaller crossing profile compared with contemporary devices. The system is intended for unilateral and purely percutaneous approach, thus simplifying and significantly shortening the procedure.
http://www.endospan.com
|
|
Pi-R Squared
Pi-R Squared Ltd. is a medical device start-up company developing a novel low profile catheter for the treatment of aortic stenosis. The company's proprietary technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. This treatment, which only takes several seconds, is intended to increase the valve effective orifice area without the need to replace the valve.
|
|
CARDIAPEX
CARDIAPEX Ltd. is an Israeli-based R&D-stage start-up company that is developing and will bring to market a novel trocar-like access and closure device that will facilitate transapical intra-cardiac procedures, including Transcatheter Aortic Valve Implantation (TAVI) and Transcatheter Mitral Valve Implantation. Currently, in order to gain access to the apex for the purposes of transcatheter valve implantation, a 5-7 cm intercostal incision is made even though the catheters delivered through the apex itself require an opening less than 1cm across.
|
| Sold Companies |
| |
|
Ophthalmic Imaging Systems (Sold to Merge Healthcare, NASDAQ: MRGE)
Ophthalmic Imaging Systems (OIS) is a leading provider of ophthalmic imaging and informatics solutions. OIS was the first investment of Accelmed (closed Q2/2009) and was sold two years later (Q2/2011) to Merge Healthcare.
http://www.merge.com
|
|
Edge Medical (Sold to Claymount)
Edge Medical Devices is the developer and manufacturer of Plasma DR flat-panel X-ray detector technology for digital radiography. Edge was the second investment of Accelmed (closed Q2/2009) and was sold two years later (Q3/2011) to Claymount, a leading multi-national X-ray player backed by ABN-Amro.
http://www.claymount.com
|
.png)
